AxioMed’s lumbar viscoelastic total disc replacement PMA Module II was submitted to FDA on January 28, 2022.
The AxioMed viscoelastic disc replacement properties allow for a single-piece design with four to 12 degrees of lordosis. It acts identical to the normal human disc to restore disc height and provide for shock absorption.
“We are already working on the third and final module to submit by April to complete the full FDA submission,” said John Sullivan, VP of Global Quality Affairs and Regulatory Compliance for the KICVentures Group.
U.S. surgeons can soon join surgeons in Australia, Europe and the Caribbean who have used the cervical and lumbar discs in spine surgery clinically.
AxioMed's lumbar viscoelastic total disc replacement PMA Module II was submitted to FDA on January 28, 2022.
The AxioMed viscoelastic disc replacement properties allow for a single-piece design with four to 12 degrees of lordosis. It acts identical to the normal human disc to restore disc height and provide for shock absorption.
“We are already...
AxioMed’s lumbar viscoelastic total disc replacement PMA Module II was submitted to FDA on January 28, 2022.
The AxioMed viscoelastic disc replacement properties allow for a single-piece design with four to 12 degrees of lordosis. It acts identical to the normal human disc to restore disc height and provide for shock absorption.
“We are already working on the third and final module to submit by April to complete the full FDA submission,” said John Sullivan, VP of Global Quality Affairs and Regulatory Compliance for the KICVentures Group.
U.S. surgeons can soon join surgeons in Australia, Europe and the Caribbean who have used the cervical and lumbar discs in spine surgery clinically.
Copy to clipboard 
